Arca
Skip to content

Stellaris Pc Vision Enhancement System

Unit, Phacofragmentation. 510(k) K101325, from Bausch & Lomb, Inc. (Rochester, NY). Product code HQC, class 2.

As of Nov 17, 2026, K101325 is an FDA 510(k) held by Bausch & Lomb, Inc., substantially equivalent on Aug 17, 2010 after 97 days, with 1 recall tied to it in FDA's recall database.

  • Substantially equivalent: Aug 17, 2010
  • Review time: 97 days
  • Recalls: 1
  • Cited as a predicate by: 3 devices

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

3 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K101325, newest first; each opens FDA's recall record
StartedReasonStatus
Aug 31, 2012Z-0593-2013Posterior fluidics modules installed in the system may need to be recalibrated.Terminated

Other HQC Clearances

The newest 510(k)s for the same product code; their median review was 267 days; see every HQC device

Record

Type
Traditional, third-party review
Received
May 12, 2010
Review panel
Ophthalmic
Regulation
21 CFR 886.4670

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.